HOOKIPA Pharma Inc. Email Format

Biotechnology ResearchNew York, United States51-200 Employees

At HOOKIPA, we envision a world in which cancers and infectious diseases can be chronically managed or eradicated. 

HOOKIPA Pharma Inc. (NASDAQ: HOOK) is a clinical-stage biopharmaceutical company advancing the field of immunotherapy through the development of new immunotherapies based on our proprietary arenavirus platform, which is designed to mobilize and amplify targeted T cells and thereby fight or prevent serious disease.

Our pipeline includes wholly owned investigational arenaviral immunotherapies targeting HPV16+ cancers, prostate cancer, KRAS-mutated cancers (including colorectal, pancreatic and lung), and other undisclosed programs. In addition, HOOKIPA aims to develop functional cures for HBV and HIV in collaboration with Gilead.

As a company, we fight for innovation; we challenge ourselves to act authentically and transparently; we thrive on our differences; and we go for it, never giving up in our efforts to eliminate the suffering of people with cancer and infectious disease.

To learn more please visit www.hookipapharma.com. 

✕

Access Insights for HOOKIPA Pharma Inc. and Millions of Other Companies

Sign up for full access to HOOKIPA Pharma Inc. information. No credit card needed.

Continue with GoogleContinue with Microsoft

OR

Work email

Create AccountBy creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Sign up for free to view info

Company overview Employee directory